COPD
From the Journals
Less CPAP time linked to exacerbation in COPD/OSA overlap syndrome
Among patients with COPD and OSA, average time of CPAP use per night was significantly higher in patients with no exacerbation.
From the Journals
Transient opioid use linked to COPD exacerbation
Opioid exposure in the prior 7 days was associated with an 80.8% increase in the odds of exacerbation.
From the Journals
Undiagnosed COPD may change heart function before heart attacks occur
Screening patients admitted for acute coronary syndromes with respiratory measures could identify those at risk for undiagnosed COPD.
From the Journals
COPD adds complexity to shared decision making for LDCT lung cancer screening
Current guidelines stress the importance of shared decision making, with discussion of the risks and benefits of screening.
Conference Coverage
Best inhaler for COPD is the one the patient will use
COPD patients should bring their inhalers back and demonstrate its use on every visit.
From the Journals
Statin use linked to less depression, anxiety in ACOS patients
Asthma–chronic obstructive pulmonary disease overlap syndrome patients who used statins with or without either inhaled or oral corticosteroids had...
From the Journals
COPD eosinophil counts predict steroid responders
Triple therapy with an inhaled corticosteroid is particularly helpful for patients with chronic obstructive pulmonary disease (COPD) who have high...
From the Journals
New COPD subtypes help refine risk
By combining visual and quantitative data from CT, a more complex picture of COPD emerges – and the possibility of varying underlying mechanisms...
From the Journals
Patients with COPD at heightened risk for community-acquired pneumonia requiring hospitalization
COPD patients were about 18 times more likely to develop community-acquired pneumonia requiring hospitalization.
From the Journals
C-reactive protein testing reduced antibiotic prescribing in patients with COPD exacerbation
Fewer prescriptions, less reported antibiotic use, with no evidence of harm or reduced quality of life, according to PACE trial investigators.